Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 11.02B | 11.17B | 9.35B | 10.03B | 10.45B | 7.36B |
Gross Profit | 4.03B | 4.25B | 2.58B | 3.46B | 4.55B | 2.69B |
EBITDA | 1.60B | 1.58B | 579.65M | 1.04B | 1.81B | 500.81M |
Net Income | 740.49M | 911.88M | -408.66M | 45.29M | 1.55B | 87.12M |
Balance Sheet | ||||||
Total Assets | 16.39B | 15.93B | 15.98B | 16.20B | 14.61B | 11.30B |
Cash, Cash Equivalents and Short-Term Investments | 2.84B | 2.41B | 2.69B | 2.61B | 2.39B | 3.02B |
Total Debt | 5.91B | 5.34B | 6.37B | 6.01B | 4.09B | 5.11B |
Total Liabilities | 7.94B | 7.47B | 8.49B | 8.20B | 6.52B | 6.93B |
Stockholders Equity | 8.45B | 8.46B | 7.48B | 8.00B | 8.09B | 4.37B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 915.12M | -178.77M | -1.42B | -1.70B | -375.25M |
Operating Cash Flow | 0.00 | 1.60B | 451.87M | -423.12M | 1.66B | -114.49M |
Investing Cash Flow | 0.00 | -695.59M | -633.76M | -1.07B | -3.34B | -225.17M |
Financing Cash Flow | 0.00 | -1.06B | 144.43M | 1.64B | 932.90M | 575.07M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥3.55B | 15.56 | 2.53% | 1.87% | -4.33% | ||
71 Outperform | ¥7.40B | 8.12 | 1.92% | 19.43% | ― | ||
71 Outperform | ¥5.02B | 11.56 | 1.47% | 2.02% | 5.55% | ||
70 Outperform | ¥177.14B | 11.15 | 6.29% | 3.43% | 3.91% | 3.49% | |
66 Neutral | ¥6.45B | 8.93 | 3.52% | 0.26% | 82.94% | ||
60 Neutral | ¥1.66B | 13.70 | 1.84% | -5.33% | -40.81% | ||
47 Neutral | ¥4.39B | 20.50 | ― | 9.52% | 88.23% |